Search results for " Biopharm" in Articles / App Notes
Article
Impact of Media Components on CQAs of Monoclonal Antibodies
Mammalian cells meet these criteria quite efficiently by virtue of their post-translation modification system, and this has made them a dominant production system for the biopharmaceutical industry. M…
Article
N-Glycan Analysis of Biotherapeutic Proteins
Of these, mAbs represent a large proportion of biotherapeutic glycoproteins and account for approximately half of the biopharmaceutical market, a trend that is set to continue with the advent of biosi…
Article
Speed and Flexibility Are Dual Goals for Biopharma Operations
Rita Peters, editorial director of BioPharm International shares insight on technologies and trends observed at the show.
What trends did the BioPharm International editorial team observe about …
Article
Impact of Manufacturing-Scale Freeze-Thaw Conditions on a mAb Solution
Therapeutic monoclonal antibodies (mAbs) represent a rapidly growing area in the biopharmaceutical sector (2). Enormous success achieved with mAbs can be attributed to their distinctive beneficial pro…
Article
Ensuring the Biological Integrity of Raw Materials
Creasey, MilliporeSigma’s head of applied solutions strategic marketing and innovation tells Biopharm International. To reduce testing delays, MilliporeSigma offers its Milliflex Quantum system, a flu…
Article
Microbiological Testing: Time is of the Essence
Challener
Effective microbiological testing during biopharmaceutical drug development and manufacturing is crucial for ensuring sterility, determining antimicrobial effectiveness, detecting microbi…
Article
Design and Qualification of Single-Use Systems
Martin
Single-use technologies (SUT) have made significant inroads in biopharmaceutical and vaccine manufacturing. Greater adoption in the years to come can be anticipated, given their broad use i…
Article
Biosimilars: Making the Switch Comes with Challenges
Market trends
Biosimilar versions of granulocyte-colony stimulating factor (G-SCF) have now gained a market share of more than 50%, Carol Lynch, global head of Sandoz Biopharmaceuticals said durin…
Article
An Integrated Approach to Ensure the Viral Safety of Biotherapeutics
Testing product and process intermediates alone is helpful, but does not provide a complete solution to viral safety. This article proposes integrated solutions for systemic and proactive viral risk m…
Article
A Q&A on Bioprocessing Trends and Technologies at INTERPHEX 2016
Rita Peters, editorial director of BioPharm International, shares some observations of announcements and activities at the event.
What developments with single-use systems were discussed?
Ther…